CD47/HIF-1α电路在肝细胞癌中促进细胞增殖
Cuicui Xu1, Yuhui Pei1, Xiaoman Zhang1
1Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, Xinjiang, China; NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, Shihezi University, Shihezi, Xinjiang, China.
肝细胞癌 (HCC) 显示了CD47表达的增加,通过稳定HIF-1α来驱动瘤生长. 向CD47和HIF-1α可能会改善HCC治疗结果.
科学领域:
- 肝胆道癌症 肝胆道癌症
- 分子瘤学分子瘤学
- 癌症信号通路 癌症信号通路
背景情况:
- 肝细胞癌 (HCC) 是一种常见的消化系统癌症,预后不佳.
- 增加CD47表达与各种癌症的不良结果有关,但其在HCC中的作用尚未完全理解.
研究的目的:
- 研究CD47在肝细胞癌 (HCC) 进展中的作用和潜在机制.
- 探索CD47表达和HCC患者瘤特征之间的关系.
主要方法:
- 通过在线数据库和免疫组织化学,评估了HCC组织中的CD47表达与邻近组织的表达.
- 通过细胞计数套件-8和殖民地形成试验评估CD47对HCC细胞增殖的影响.
- 利用生物信息学,qRT-PCR和西部涂抹来阐明CD47的调节机制.
主要成果:
- 在HCC组织中,CD47表达显著更高,与瘤阶段相关.
- 过度表达CD47促进了HCC细胞的增殖,而沉默CD47则抑制了它.
- HIF-1α直接调节CD47转录,CD47通过抑制其降解来稳定HIF-1α,形成一个正反循环.
结论:
- CD47在HCC上调节,并与HIF-1α形成正反循环,加速瘤生长.
- 准CD47-HIF-1α轴为HCC提供了一个潜在的治疗策略.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
相关概念视频
Abnormal Proliferation
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
